| Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis. | None |
| Tumor promoter arsenite stimulates histone H3 phosphoacetylation of c-fos and this proto-oncogene chromatin in diploid fibroblasts. | None |
| Tumor promoter arsenite stimulates histone H3 phosphoacetylation of proto-oncogenes c-fos and c-jun chromatin in human diploid fibroblasts. | None |
| Oncogenic effect of delta deletion in v-Jun does not result from uncoupling Jun from JNK signaling. | None |
| Phosphorylation of c-jun was induced by TPA only. On the other hand, expression of proto-oncogene c-jun was induced by TPA and Saikosaponin a during 30 min to 6 h of treatment. | None |
| ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a. | None |
| Partial oncogenic transformation of chicken embryo fibroblasts by Jun dimerization protein 2, a negative regulator of TRE- and CRE-dependent transcription. | None |
| Fos and Jun: oncogenic transcription factors. | None |
| No correlation between ras, c-myc and c-jun proto-oncogene expression and prognosis in advanced carcinoma of cervix. | None |
| [Expression of oncogene C-jun in the cells of rat nasal mucosa and relevance with rhinorrhea]. | None |
| Ras protects Rb family null fibroblasts from cell death: a role for AP-1. | None |
| Oncogenic transformation by Jun: role of transactivation and homodimerization. | None |
| [Expression of c-jun and c-fos oncogene in medulloblastoma and its clinical significance]. | None |
| A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function. | None |
| Insulin-like growth factor I stimulates transcription of the c-jun proto-oncogene in Balb/C 3T3 cells. | None |
| Mitogen regulated induction of FRA-1 proto-oncogene is controlled by the transcription factors binding to both serum and TPA response elements. | None |
| TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway. | None |
| The proto-oncogene c-jun ia novel target gene of Aryl hydrocarbon receptor. | None |
| Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway. | None |
| Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. | None |